You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 10, September 13, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cardiac Involvement in a Large Kindred With Myotonic Dystrophy

Quantitative Assessment and Relation to Size of CTG Repeat Expansion

Lale S. Tokgozoglu, MD; Tetsuo Ashizawa, MD; Antonio Pacifico, MD; Richard M. Armstrong, MD; Henry F. Epstein, MD; William A. Zoghbi, MD

JAMA. 1995;274(10):813-819.


Abstract

Objective.
—To evaluate and quantitate cardiac involvement in myotonic dystrophy and assess whether the size of the trinucleotide (cytosine-thymine-guanine [CTG]) repeat expansion is a significant predictor of cardiac abnormalities.

Design.
—Case-control study of a large kindred with myotonic dystrophy.

Patients.
—Ninety-one bloodline members of the kindred underwent clinical and cardiac evaluation with electrocardiograms, echocardiography (with Doppler in the majority of cases), and genetic and neurologic evaluations. Affected individuals were age-matched to normal family members.

Main Outcome Measures.
—Electrocardiographic conduction abnormalities, wall motion abnormalities, mitral valve prolapse, and global parameters of systolic and diastolic function were determined by an observer blinded to all clinical data and genetic analysis.

Results.
—Compared with age-matched normals, patients with myotonic dystrophy (n=25) were more likely to have conduction abnormality (52% vs 9%), mitral valve prolapse (32% vs 9%), and wall motion abnormality (28% vs 0%) (all P<.05). Left ventricular ejection fraction and stroke volume were reduced compared with normals matched for age and heart rate (P<.05), whereas Doppler indexes of diastolic function were only marginally altered. Using multivariate analysis, the number of CTG repeats (range, 69 to 1367; normal, ≤37) was the strongest predictor of abnormalities in wall motion and electrocardiographic conduction (odds ratio of 16.5 and 5.07 per 500 repeats, respectively). The relation of mitral valve prolapse to the size of the CTG repeat was of borderline significance. Patients with more extensive neurologic findings (n=12) had a higher incidence of wall motion and/or electrocardiographic conduction abnormalities (83% vs 43%; P=.04).

Conclusions.
—Cardiac involvement in myotonic dystrophy affects predominantly the conduction system and myocardial function. Alterations in myocardial relaxation and diastolic properties, in contrast to skeletal muscle myotonia, are minor. In this kindred, the number of CTG repeats was a significant predictor of cardiac dysfunction in myotonic dystrophy.

(JAMA. 1995;274:813-819)



Author Affiliations

From the Department of Medicine, Section of Cardiology (Drs Tokgozoglu, Pacifico, and Zoghbi), the Department of Neurology (Drs Ashizewa, Armstrong, and Epstein), Baylor College of Medicine and Veterans Affairs Medical Center, and the Echocardiography Laboratory, The Methodist Hospital (Drs Tokgozoglu and Zoghbi), Houston, Tex. Dr Tokgozoglu is now with the Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.


Footnotes

Presented in part at the 67th Annual Scientific Session of the American Heart Association, Dallas, Tex, November 16, 1994.

Reprint requests to Echocardiography Research, The Methodist Hospital, 6550 Fannin, SM-677, Houston, TX 77030 (Dr Zoghbi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiac involvement in muscular dystrophies
Beynon and Ray
QJM 2008;101:337-344.
ABSTRACT | FULL TEXT  

Nuclear RNA Foci in the Heart in Myotonic Dystrophy
Mankodi et al.
Circ. Res. 2005;97:1152-1155.
ABSTRACT | FULL TEXT  

Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
Clarke et al.
Heart 2001;86:411-416.
ABSTRACT | FULL TEXT  

Clinical Epidemiological Quality in Molecular Genetic Research: The Need for Methodological Standards
Bogardus et al.
JAMA 1999;281:1919-1926.
ABSTRACT | FULL TEXT  

Relationships Among Electrophysiological Findings and Clinical Status, Heart Function, and Extent of DNA Mutation in Myotonic Dystrophy
Lazarus et al.
Circulation 1999;99:1041-1046.
ABSTRACT | FULL TEXT  

Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips et al.
Science 1998;280:737-741.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.